Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTBVAC Dose-Defining Study in South African Neonates
NCT03536117Phase 2Completed
- Sponsor
- Biofabri
- Start
- Feb 2019
- Primary completion
- May 2022
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of mtbvac in Tuberculosis (TB), sponsored by Biofabri. Started Feb 2019; status: completed.
02
Drugs
mtbvac
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03536117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03536117.